Docking studies for melatonin receptors.

Hanan Awad Alkozi, José Maria Sánchez Montero, Antonio Luis Doadrio, Jesus Pintor

Journal: Expert opinion on drug discovery 2019;13(3):241-248

PMID: 29271261

Abstract

Melatonin is a neurohormone that controls many relevant physiological processes beyond the control of circadian rhythms. Melatonin's actions are carried out by two main types of melatonin receptors; MT and MT. These receptors are important, and not just because of the biological actions of its natural agonist; but also, because melatonin analogues can improve or antagonize their biological effect. Area covered: The following article describes the importance of melatonin as a biologically relevant molecule. It also defines the receptors for this substance, as well as the second messengers coupled to these receptors. Lastly, the article describes the amino acid residues involved in the docking process in both MT and MT melatonin receptors. Expert opinion: The biological actions of melatonin and their interpretations are becoming more relevant and therefore require the development of new pharmacological tools. Understanding the second messenger mechanisms involved in melatonin actions, as well as the characteristics of the docking of this molecule to MT and MT melatonin receptors, will permit the development of more selective agonists and antagonists which will help us to better understand this molecule as well to develop new therapeutic compounds.

Address: a Department of Biochemistry and Molecular Biology IV, Faculty of Optometry , Universidad Complutense de Madrid , Madrid , Spain.; b Department of Organic Chemistry and Pharmaceutical, Faculty of Pharmacy , Ciudad Universitaria , Madrid , Spain.; c Department of Inorganic Chemistry and Bioorganic, Faculty of Pharmacy , University Complutense of Madrid , Ciudad Universitaria, Madrid , Spain.

Link outs

Free resources

Other Literature Sources:

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.